$NWBO
It was Thomas Owen McCaffrey who told the Hollensbes about @NorthwestBio’s DCVax-L platform and introduced them to Dr. Linda Liau at @UCLAStrokeNSG
Thomas is an 11-year glioblastoma survivor after taking part in a Phase 3 clinical trial run by Dr. Liau.
@ThomasOwenMcCa1 was 39 years old and a new dad when he suffered a Grand Mal seizure in his Sherman Oaks, California kitchen
His son Jake was just three months old at the time.
He will turn 12 in December.
And Thomas has been there for the moments glioblastoma tried to steal from him.
@SpimacoAddwaeih@aljedai@MHRAgovuk@UKParliament@FDA
🚨 FORMAL SEC FILING SUBMITTED — POSSIBLE $OPEN MARKET MANIPULATION
As I promised, I followed this all the way through.
With the support of my legal counsel, the full dossier regarding the unusual trading activity observed in Opendoor Technologies ($OPEN) has now been formally submitted to the U.S. Securities and Exchange Commission.
The SEC has confirmed receipt.
The submission includes the underlying datasets, order-level analysis, cross-venue comparisons, event timelines, counter-evidence, methodology and the specific patterns that I believe warrant independent regulatory review.
To be absolutely clear: I am not claiming that manipulation has already been proven.
That is precisely why the material is now where it belongs — with the authorities that have access to information retail investors do not, including the ability to reconstruct order activity and identify the entities behind it.
I was genuinely pleased to see @rabois acknowledge my previous analysis.
@nejatian , I also want to say this with genuine respect: I have a great deal of confidence in what you are trying to build at Opendoor, and I fully understand that your position as CEO places obvious limits on what you can appropriately say about a matter like this.
I simply hope this concern has reached you.
I see you as an important figure not only in Opendoor’s transformation, but also in representing the long-term interests of its shareholders. Precisely because I respect your leadership, I hope Opendoor will support any appropriate regulatory review and cooperate fully should the authorities decide that these patterns deserve a deeper examination.
This has never been about creating noise around the company. Quite the opposite.
If there is nothing improper here, an independent review can help establish that clearly.
If there is something improper, shareholders deserve to know.
Either outcome serves the same principle:
market integrity and shareholder protection.
I did my part.
The evidence is now in regulatory hands.
$OPEN
Dr. Prins just dropped the UCLA ATL-DC + Keytruda data at EANO in Rome.
Same exact dendritic cell platform.
Same doctors who built DCVax-L.
In recurrent GBM they showed that giving the vaccine FIRST then adding PD-1 blockade delivered 555 days median survival vs only 271 days when they flipped the order.
That’s not a rounding error.
That’s the difference between the immune system actually getting a chance to work and it not.
Sequence matters.
This is the same science.
The takeaway is simple: the vaccine works, the order you give it in changes everything, and this is the exact same platform NWBO has been running for years.
$NWBO
Sounds like the same ALGORITHMIC MARKET MANIPULATION in the ongoing $NWBO Lawsuit. Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC et al is a federal securities fraud and market manipulation lawsuit active in the U.S. District Court for the Southern District of New York under Case No. 1:22-cv-10185-GHW-GS . If this is the case, be prepared for the share price to be manipulated down to pennies 🫤 @realDonaldTrump@SECGov
I have been waiting almost 3 years to write these words:
NO EVIDENCE OF DISEASE. 🙏❤️
Today we met with Braelyn’s neurosurgeon, Dr. Linda Liau at UCLA (telehealth).
When our local radiologist read Braelyn’s August 28 MRI as “no evidence of disease recurrence,” we were thrilled—but I was afraid to fully exhale.
I knew Dr. Liau and the UCLA tumor board would scrutinize every millimeter of those images.
What if they saw something the local radiologist missed?
Today, Dr. Liau told us that she and the tumor board had thoroughly reviewed Braelyn’s MRI.
They were amazed.
There is NO VISIBLE TUMOR.
Even the ~10% Dr. Liau had to leave behind during surgery because of its intimate involvement with critical structures is no longer visible.
She emphasized how amazed and pleased the entire tumor board was by such a complete response at this point.
Her assessment: the prior radiation and the ongoing DCVax appear to be working very well.
Their recommendation after also reviewing the Keytruda regimen Braelyn recently started?
KEEP DOING WHAT SHE’S DOING.
😭🙏
First and foremost, we give ALL thanks and glory to God.
People all over the world have prayed for this girl. I cannot begin to express how humbled and grateful we are.
But tonight I also cannot stop thinking about how close Braelyn came to never having this opportunity.
Earlier this year, her tumor was enormous and growing rapidly.
We sought help from multiple surgeons—including at prestigious institutions.
We were told further surgery was too risky.
We were offered the same old options: chemotherapy and photon radiation that would affect most of her brain, given the size of her tumor.
Her tumor is MGMT-unmethylated, so for Braelyn, chemo was all risk with little to no benefit.
And then a stranger I met here on X changed everything. @ThomasOwenMcCa1 connected us with Dr. Liau.
After reviewing Braelyn’s case, one of the first things she said was:
“This girl needs surgery right away.”
I told her we knew that. We just couldn’t find anyone willing to do it.
I asked if SHE would.
“If you can get her to me, I will do her surgery.”
We got Braelyn to UCLA.
Within two weeks, Dr. Liau operated and removed ~90% of a massive tumor spanning three lobes, stopping where continuing would risk critical structures.
And this time, her tumor tissue was PROPERLY PRESERVED.
That tissue was ultimately sent to England and used to manufacture Braelyn’s personalized DCVax vaccine.
She has now received 3 induction doses + her first booster.
And today?
The tumor that Dr. Liau had to leave behind is no longer visible on MRI.
Think about that.
And then think about what could have happened if we had simply accepted “there’s nothing else we can do.”
THIS is why I will not stop advocating for reform.
Patients should not have to find potentially life-saving treatment options accidentally through strangers on social media.
Patients should be told about legitimate investigational options when standard treatment offers little hope.
Patients undergoing tumor surgery should be informed BEFORE surgery about preservation of tissue that could potentially be used for personalized treatments.
And patients should have the right to make informed decisions about which risks they are willing to take.
Promising science means very little if the patients who need it cannot access it.
Braelyn is living proof of why access matters.
Tonight, though, advocacy can wait for just a moment.
Tonight I’m her mom.
And I finally get to say the words I have begged God to someday let me say:
NO EVIDENCE OF DISEASE.
Thank You, God.
Thank you, Dr. Liau.
Thank you to everyone who opened a door, donated, shared her story, fought for her and prayed for our girl.
There is always light, even in the darkest places.
Tonight that light is shining incredibly bright. ❤️🙏
#DCVaxForBraelyn #CureNotCovered
@greta@kshaughnessy2@andrewcaravello
Sending prayers for Bubba 🙏🙏🙏 I just came across your page and have been reading through your posts. I'm not sure what type of Brain Cancer Bubba had. If you haven't heard about DCVax and Northwest Bio #NWBO, I encourage you to following the accounts of @HollensbeAmanda, a mother who's daughter had Glio brain tumor (no evidence of disease after receiving DCVax ) and @ThomasOwenMcCa1 a Glio survivor for 11 years after receiving DCVax as a participant in the Trial. Currently waiting approval in the UK @MHRAgovuk Also follow @andrewcaravello a Dr who breaks down the science behind DCVax. I will continue to say prayers for you and your precious Bubba 💗🙏
Dr. Robert Prins from UCLA will be presenting the results of the combination therapy of DCVax/Keytruda/Poly ICLC at EANO on Friday, and these results have NEVER been seen before in GBM. Buckle up!!! $NWBO ✌️😁https://t.co/FrOIeVXgJo
WHEN THE SYSTEM MOVES TOO SLOW… A COMMUNITY BECOMES THE MOMENTUM
Something is happening around DCVax.
More people are sharing. More patients are discovering the story. More voices are asking questions. Our community is growing… and we’re breaking through.
We’ve watched @Greta use her platform. We’ve watched @DrOz comment on Braelyn’s story. And we’ve heard her story has reached President Trump @POTUS@realDonaldTrump.
More importantly… there is a mother fighting like hell to save her daughter.
@HollensbeAmanda has relentlessly shared Braelyn’s journey through an uphill battle no mother should ever have to fight.
After a devastating Grade 4 brain cancer diagnosis… Braelyn began DCVax treatment.
Approximately three months later came the words Amanda had waited almost three years to write…
NO EVIDENCE OF DISEASE.
After Dr. Linda Liau and the UCLA tumor board reviewed the imaging…
NO VISIBLE TUMOR.
Even the portion that couldn’t safely be removed during surgery was no longer visible.
Think about that.
A young girl fighting one of medicine’s most aggressive cancers… treated with a personalized vaccine designed to educate her own immune system to recognize tumor-associated targets… and months later NO VISIBLE TUMOR.
How is the cancer world not talking about this?
We hear constantly about mRNA cancer vaccines and Big Pharma programs. Their announcements command worldwide headlines and tens of billions added in market value overnight.
Fine. Investigate them.
BUT INVESTIGATE THIS TOO.
DCVax uses a patient’s own dendritic cells to help mobilize their immune system against their cancer.
DCVax-L was designed for operable solid tumors… DCVax-Direct for inoperable solid tumors.
Now ask the bigger question…
What if cancer itself is only the beginning?
What if this technology someday opens doors into autoimmune disease… infectious disease… or areas of medicine we haven’t contemplated yet?
With a completed Phase III trial, peer-reviewed published results and patients desperately needing options… shouldn’t every legitimate accelerated regulatory pathway be taken seriously?
People facing devastating cancers deserve informed choices when the alternative may be running out of time.
What if DCVax becomes a very real option in the standard of care?
What if someday cutting, burning and poisoning are no longer the center of cancer treatment… but replaced or complemented by treatments teaching our own immune systems how to fight?
Another story deserves daylight too.
NWBO is pursuing federal litigation alleging spoofing and manipulation of its stock by major market participants.
Where are the financial journalists? Where is @cvpayne?
Come look. Ask questions. Follow the evidence.
Cancer has taken far too many mothers, fathers, sons, daughters, brothers, sisters and friends.
This isn’t left or right. It isn’t politics.
It’s human life.
And to the independent voices willing to investigate stories others overlook… @TuckerCarlson, @RealCandaceO, @ShawnRyan762 and others with the reach to shine light into dark places…
THE PATIENTS AND FAMILIES ARE HERE.
Amanda and Braelyn are here.
Thomas and other DCVax survivors are here.
They’re willing to tell their stories far and wide.
Interview them. Ask the difficult questions. Hear what they’ve lived through firsthand.
GIVE THEM THE MICROPHONE.
Follow the science and decide for yourself whether the world should be paying attention.
Behind every clinical trial… every regulatory filing… every ticker… there is a human being waiting for more time.
If mainstream media won’t find the story… we bring the story to them.
Keep sharing. Keep asking. Keep digging.
WE ARE MAKING A DIFFERENCE.
And when the system moves too slow…
A COMMUNITY BECOMES THE MOMENTUM.
👇 See it for yourself:
https://t.co/qjTBJ4pXMO
https://t.co/WF6BT59T4v
$NWBO #DCVax #Glioblastoma
$NWBO #DCVax#Glioblastoma#DCVaxForBraelyn
A special shoutout to @ThomasOwenMcCa1 for continuing to be an inspiration to the glioblastoma community, including Braelyn and so many other patients and families walking this road.
Stories like his are a reminder of why understanding the science matters.
Here’s another explainer video breaking down, in simple terms, how DCVax works and the mechanism behind the immune response it is designed to generate.
@greta@peterjkostis@kshaughnessy2@HollensbeAmanda@HollensbeAmanda@MHRAgovuk@FDA
🌶️🔥🌶️🔥🌶️🔥🌶️🔥🌶️🔥🌶️🔥🌶️🔥
🚨 $NWBO — NEW COURT FILINGS
⚖️ Northwest Biotherapeutics v. Canaccord, et al.
🏛️ SDNY | Case No. 1:22-cv-10185-GHW-GS
📅 Filed 09/16/2026
⚠️ Not legal advice. Layman’s summary. These are NWBO’s allegations—not court findings. (All supporting filings will be shared via Dropbox below or in the comment section.)
📄 Doc. 345 — Motion to Seal
🔒 NWBO asks to temporarily seal Appendix A because it describes materials defendants designated “Highly Confidential.” NWBO takes no position on permanent sealing.
🔥 Doc. 346 — NWBO’s Main Response
🧩 NWBO argues defendants are playing a word game—denying “algorithmic trading” under narrow definitions while admitting automated systems handled routing, quotations, orders & executions.
💥 NWBO calls the denials:
“at best selective wordplay, at worst outright falsehoods.”
🤖 NWBO says the limited trading data already produced shows automated decision-making:
🔹 Citadel: Systems allegedly created “child orders,” changed prices or quantities, modified quotes & sometimes held back or declined executions.
🔹 Virtu: Systems allegedly altered order characteristics & declined certain marketable transactions within seconds.
🔹 GTS: Data allegedly shows multiple distinct orders placed in less than one second—faster than a person could manually enter them.
🔹 G1X: Admits its automated system decided whether to fill, route, link, hold or display orders—but disputes calling that “algorithmic.”
🔹 Instinet: NWBO identifies “smart routing” systems & specific routing codes.
🔹 Lime: NWBO seeks routing source code, deanonymized trading records & identification of the programs handling particular orders.
📣 NWBO asks the court to order production of relevant source code, system designs, technical specifications & communications.
📎 Doc. 346-1 — Exhibit 1
📝 NWBO’s interrogatories define an algorithm broadly as automated or semi-automated rules, logic or code controlling trading, routing, timing, pricing, volume, risk or strategy.
📎 Doc. 346-2 — Exhibit 2
🏛️ A 2020 SEC staff report showing algorithmic trading has many forms—not one narrow definition.
📎 Doc. 346-3 — Exhibit 3
🔍 NWBO’s requests seek trading data, parent & child orders, source code, configurations, testing, communications, positions, hedging & risk information.
📎 Doc. 346-4 — Exhibit 4
⚡ A 2014 SEC review explaining that HFT, algorithmic trading & computer-assisted trading overlap—but are not identical.
📎 Doc. 346-5 — Exhibit 5
🚨 A 2020 FINRA settlement involving Citadel’s OTC order-handling systems, trading ahead, limit-order display & supervision. Citadel accepted a $700,000 fine, restitution & censure without admitting or denying the findings.
📎 Docs. 346-6 & 346-7 — Exhibits 6 & 7
💰 A 2017 SEC order & press release involving Citadel algorithms FastFill & SmartProvide. Citadel agreed to approximately $22.7 million in disgorgement, interest & penalties without admitting or denying the findings.
📎 Doc. 346-8 — Exhibit 8
🌐 Citadel’s website states:
“Cutting-edge mathematical models & algorithms power our strategies.”
📎 Doc. 346-9 — Exhibit 9
🌐 Instinet advertises “Algorithmic & automated trading,” automated workflows & routing technology.
📎 Doc. 346-10 — Exhibit 10
📘 Instinet’s policy describes its Smart Order Router as an algorithm & explains that algorithms may divide “parent orders” into multiple “child orders.”
🎯 Bottom line: NWBO argues defendants may reject the word “algorithm,” but their declarations, data, regulatory history & public materials show automated systems making meaningful trading decisions.
⚖️ NWBO wants the court to look beyond the labels & order production of the underlying code & system information. Judge Stein must now decide how much discovery defendants must produce.
https://t.co/FvfQZtvwud
https://t.co/UHcN041cPJ
Why are cancer patients and their loved ones still suffering while treatments like DCVAX-L from NWBO get little to no noise??
Simple: Greed (BP and WS fight hard to keep their investments safe)
Done through stock manipulation and Government "Donations" aka bribes 💰
Yesterday, Braelyn’s story was trending on X, and thousands of people were talking about her and $NWBO
But sadly, I didn’t see a single link to her GoFundMe. 💔
If we’re going to talk about Braelyn’s story, let’s also help her and her family. Even a small donation—or simply sharing the link—can help her continue her brain cancer treatment.
🙏 Please help Braelyn continue her fight:
https://t.co/J5dS4N6HcY
#Braelyn #BrainCancer #HelpBraelyn #GoFundMe